The life sciences and pharmaceutical sector is constantly evolving and for companies to innovate and stay ahead of the curve, they need to be ready to capitalize on opportunities. Yet, success in life sciences hinges on safely seizing these chances amid inherent risks.
Join experts from NTT DATA as they discuss the complex challenges and solutions to maintaining safety and security in cybersecurity, quality assurance & regulatory compliance.
Check out the podcast episode below.⬆
- Ep. 2 Catalyst for Change: New QA Guidelines Create Opportunities for Innovation
- Ep. 1 6 Steps to Strong Cybersecurity in Life Sciences Manufacturing
Catalyst for Change: New QA Guidelines Create Opportunities for Innovation
Quality Assurance is essential to the safe manufacturing and sale of pharmaceutical products. But efforts to meet regulatory guidelines have sometimes resulted in a risk averse approach to QA, and a hesitancy to adopt new technology and processes. New guidelines present an opportunity for life sciences and pharmaceutical companies to revolutionize their quality assurance practices. In this episode, you’ll hear from experts about the new compliance requirements, the differences between risk-based vs. opportunity-based approach to compliance and quality assurance and the benefits of focusing QA efforts on impact to product and patient.